市場調査レポート

商品コード

1408042

DNAシーケンシングの世界市場の評価、製品タイプ別、技術別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Global DNA Sequencing Market Assessment, By Product Type, By Technology, By Application, By End-users, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年01月15日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 224 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 705,420円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 893,532円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,285,432円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のDNAシーケンシングの市場規模は、2023年に81億6,000万米ドル、2031年に245億1,000万米ドルに達し、2024年～2031年の予測期間にCAGRで14.74%の成長が見込まれています。嚢胞性線維症のような慢性疾患やその他の遺伝子疾患は、DNAシーケンシングを使用して高い精度で診断されるため、市場への需要が高まっています。医薬品開発、農業研究、法医学など、さまざまな目的の遺伝子研究者の増加が、DNAシーケンシング製品に対する大きな需要を生み出し、市場をさらに促進しています。科学の研究開発に対する技術の進歩と政府の支援は、市場の発展に極めて重要な役割を果たすと予測されています。しかし、製品に関連する高いコストや、高度に熟練した専門家の不足、複雑なデータの解釈が、市場の成長抑制要因となっています。

慢性疾患と遺伝性疾患の有病率の増加

慢性疾患と遺伝性疾患の有病率の増加は、DNAシーケンシング市場の重要な促進要因です。がん、心血管疾患、その他の慢性疾患の罹患率と有病率の増加が、DNAシーケンシングに基づく診断の需要を刺激し、市場成長を促進しています。DNAシーケンシングは、これらの疾患の診断と治療において重要な役割を果たしており、関連する製品とサービスの需要の増加につながっています。特定の疾患マーカーを同定し、治療に対する個々の反応を予測するDNAシーケンシング技術の能力は、その採用を促進し、市場拡大にさらに寄与しています。2023年9月、WHOのファクトシートによると、非感染性疾患（NCD）は毎年4,100万人の死因となっており、これは世界全体の死因の74%に相当します。約1,700万人が70歳までにNCDで死亡し、その86％が中低所得国で発生しています。NCDによる死因の大半は心血管疾患（CVD）であり、次いでがん、慢性呼吸器疾患、糖尿病です。

成長する研究開発

ゲノム探索とその利益をさまざまな目的に活用するための研究開発の成長は、市場にプラスの影響を与えています。ヒトゲノムプロジェクトは過去数十年間、ゲノム探索を含む研究環境の拡大に大きく寄与しました。それとともに、サンガー技術やNGSの学術/組織研究プロジェクトでの受け入れや利用が増加し、市場は大きな成長を記録すると予測されます。

北米がDNAシーケンシング市場をリード

研究開発活動への高い投資、主要企業による技術開発、先進の医療インフラにより、米国やカナダなどの北米諸国がもっとも高い金額シェアで市場を独占すると予測されます。さまざまなDNAシーケンシング技術に対する政府の支援活動が、この地域の市場成長を後押ししています。

COVID-19の影響

COVID-19パンデミックは市場に大きな影響を与えました。COVID-19関連のケアを優先した結果、このウイルスへの対処に向けたDNAシーケンシング手法の使用が増加しましたが、同時にその他の利用は減少しました。次世代シーケンシング手法はCOVID-19の診断に大きな関心を集めました。2021年のCOVID-19患者の増加は、DNAシーケンシングを含む診断製品の需要を大幅に押し上げ、市場成長を促進しました。さらに、パンデミックはDNAシーケンシング市場のサプライチェーンにマイナスの影響を与え、成長をある程度抑制しましたが、パンデミックの規制が解除されてすぐに市場は通常のペースに戻り、予測期間には着実な成長を記録すると見込まれます。

当レポートでは、世界のDNAシーケンシング市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

市場規模と予測
- 金額
- 数量
製品タイプ別
- 消耗品
- 器具
- サービス
技術別
- サンガーシーケンシング
- 次世代シーケンシング
- その他のシーケンシング技術
用途別
- 診断用途
- 個別化医療
- 研究用途
エンドユーザー別
- 病院、医療機関
- 学術、研究機関
- 製薬企業、バイオテクノロジー企業
- その他
地域別
- 北米
- 欧州
- アジア太平洋
- 南米
- 中東・アフリカ
市場シェア：企業別（2023年）

第6章世界のDNAシーケンシング市場の見通し：地域別（2017年～2031年）

北米
- 市場規模と予測
- 製品タイプ別
- 技術別
- 用途別
- エンドユーザー別
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- イタリア
- 英国
- ロシア
- オランダ
- スペイン
- トルコ
- ポーランド
南米
- ブラジル
- アルゼンチン
アジア太平洋
- インド
- 中国
- 日本
- オーストラリア
- ベトナム
- 韓国
- インドネシア
- フィリピン
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- 南アフリカ

第7章市場マッピング（2023年）

タイプ別
技術別
用途別
エンドユーザー別
地域別

第8章マクロ環境と産業構造

需給分析
輸出入の分析 - 数量と金額
サプライ/バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第9章市場力学

成長促進要因
成長抑制要因（課題、抑制要因）

第10章規制枠組みとイノベーション

臨床試験
特許情勢
規制当局の承認
イノベーション/新技術

第11章主要企業情勢

マーケットリーダー上位5社の競合マトリクス
マーケットリーダー上位5社の市場収益分析（2023年）
合併と買収/合弁事業（該当する場合）
SWOT分析（市場参入企業5社）
特許分析（該当する場合）

第12章価格分析

第13章ケーススタディ

第14章主要企業の見通し

Illumina, Inc.
Thermo-Fischer scientific
BGI genomics
Agilent Technologies Inc.
10X Genomics
QIAGEN
F. Hoffmann-La Roche Ltd
Merck KGaA
PerkinElmer Inc.
Myriad Genetics Inc.

第15章戦略的推奨事項

第16章当社について、免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 3. Global DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 4. Global DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 5. Global DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 6. Global DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 7. Global DNA Sequencing Market Share (%), By Region, 2017-2031F
Figure 8. North America DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 10. North America DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 11. North America DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 12. North America DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 13. North America DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 14. North America DNA Sequencing Market Share (%), By Country, 2017-2031F
Figure 15. United States DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 17. United States DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 18. United States DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 19. United States DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 20. United States DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 21. Canada DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 23. Canada DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 24. Canada DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 25. Canada DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 26. Canada DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 27. Mexico DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 29. Mexico DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 30. Mexico DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 31. Mexico DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 32. Mexico DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 33. Europe DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 35. Europe DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 36. Europe DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 37. Europe DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 38. Europe DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 39. Europe DNA Sequencing Market Share (%), By Country, 2017-2031F
Figure 40. Germany DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 42. Germany DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 43. Germany DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 44. Germany DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 45. Germany DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 46. France DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 47. France DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 48. France DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 49. France DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 50. France DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 51. France DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 52. Italy DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 54. Italy DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 55. Italy DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 56. Italy DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 57. Italy DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 58. United Kingdom DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 60. United Kingdom DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 61. United Kingdom DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 62. United Kingdom DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 63. United Kingdom DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 64. Russia DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 66. Russia DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 67. Russia DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 68. Russia DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 69. Russia DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 70. Netherlands DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 72. Netherlands DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 73. Netherlands DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 74. Netherlands DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 75. Netherlands DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 76. Spain DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 78. Spain DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 79. Spain DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 80. Spain DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 81. Spain DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 82. Turkey DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 84. Turkey DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 85. Turkey DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 86. Turkey DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 87. Turkey DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 88. Poland DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 90. Poland DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 91. Poland DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 92. Poland DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 93. Poland DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 94. South America DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 96. South America DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 97. South America DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 98. South America DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 99. South America DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 100. South America DNA Sequencing Market Share (%), By Country, 2017-2031F
Figure 101. Brazil DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 103. Brazil DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 104. Brazil DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 105. Brazil DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 106. Brazil DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 107. Argentina DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 109. Argentina DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 110. Argentina DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 111. Argentina DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 112. Argentina DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 113. Asia-Pacific DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 115. Asia-Pacific DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 116. Asia-Pacific DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 117. Asia-Pacific DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 118. Asia-Pacific DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 119. Asia-Pacific DNA Sequencing Market Share (%), By Country, 2017-2031F
Figure 120. India DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 121. India DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 122. India DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 123. India DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 124. India DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 125. India DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 126. China DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 127. China DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 128. China DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 129. China DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 130. China DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 131. China DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 132. Japan DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 134. Japan DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 135. Japan DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 136. Japan DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 137. Japan DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 138. Australia DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 140. Australia DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 141. Australia DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 142. Australia DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 143. Australia DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 144. Vietnam DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 146. Vietnam DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 147. Vietnam DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 148. Vietnam DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 149. Vietnam DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 150. South Korea DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 152. South Korea DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 153. South Korea DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 154. South Korea DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 155. South Korea DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 156. Indonesia DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 158. Indonesia DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 159. Indonesia DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 160. Indonesia DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 161. Indonesia DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 162. Philippines DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 164. Philippines DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 165. Philippines DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 166. Philippines DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 167. Philippines DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 168. Middle East & Africa DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 170. Middle East & Africa DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 171. Middle East & Africa DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 172. Middle East & Africa DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 173. Middle East & Africa DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 174. Middle East & Africa DNA Sequencing Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 177. Saudi Arabia DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 178. Saudi Arabia DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 179. Saudi Arabia DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 180. Saudi Arabia DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 181. UAE DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 183. UAE DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 184. UAE DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 185. UAE DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 186. UAE DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 187. South Africa DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa DNA Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 189. South Africa DNA Sequencing Market Share (%), By Product Type, 2017-2031F
Figure 190. South Africa DNA Sequencing Market Share (%), By Technology, 2017-2031F
Figure 191. South Africa DNA Sequencing Market Share (%), By Application, 2017-2031F
Figure 192. South Africa DNA Sequencing Market Share (%), By End-users, 2017-2031F
Figure 193. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX10838

Global DNA sequencing market size was valued at USD 8.16 billion in 2023, which is expected to reach USD 24.51 billion in 2031, with a CAGR of 14.74% for the forecast period between 2024 and 2031F. The global DNA sequencing market is a highly dynamic and promising market with a robust product and favorable market strategies. Healthcare professionals can diagnose chronic diseases with pinpoint accuracy which can facilitate the drafting of effective treatment and disease management strategies. Genetic mutation leading to chronic disease can be detected early using DNA sequencing. Several chronic diseases and other genetic disorders like cystic fibrosis are diagnosed using DNA sequencing with high precision, thus there is a growing demand for the market. The increasing number of genetic researchers for different purposes, like drug development, agricultural research, and forensics, creates a huge demand for DNA sequencing products, further driving the market. Technological advancements and government support for scientific research and development are expected to play a pivotal role in developing the market. However, the high cost associated with products, the lack of highly skilled professionals, and the interpretation of complicated data are some of the hindrances in the growth of the global DNA sequencing market.

In September 2023, Integrated DNA Technologies (IDT), announced the launch of xGen NGS products designed exclusively for the Ultima Genomics UG 100™ platform. The launch package of new xGen NGS tools comprised of adapters, primers, and universal blockers. It can support a wide range of applications, including DNA, RNA, and methylation sequencing workflows. The xGen NGS aims to minimize the possible errors in sequencing, thus improving overall outcomes.

Growing Prevalence of Chronic Diseases and Genetic Disorders

The growing prevalence of chronic diseases and genetic disorders is a significant driver of the DNA sequencing market. The increasing incidence and prevalence of cancer, cardiovascular diseases, and other chronic ailments are fueling the demand for DNA sequencing-based diagnosis, driving market growth. DNA Sequencing plays a substantial role in the diagnosis and treatment of these diseases, leading to a rising demand for related products and services. The ability of DNA sequencing techniques to identify specific disease markers and predict individual responses to treatments is driving their adoption, further contributing to market expansion. In September 2023, according to a factsheet by WHO, noncommunicable diseases (NCDs) are responsible for killing 41 million people each year, equivalent to 74% of all deaths globally. Around 17 million people die from an NCD before the age of 70 years; 86% of these premature deaths occur in low- and middle-income countries. Cardiovascular diseases (CVDs) account for most NCD deaths, (17.9 million people annually), followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million).

Growing Research and Development

Growing research and development around genome exploration and utilizing its benefits for several purposes is positively impacting the global DNA sequencing market. The human genome project contributed a lot in the past few decades to the increasing research environment involving genome expeditions. Along with that, increased acceptance, and usage of sanger technology and NGS in academic and institutional research projects, the market is expected to register significant growth. In November 2023, UK Biobank Limited released the world's largest-by-far single set of sequencing data in the public domain after consistent research for five years with an investment of EUR 200 million. The data is set to drive the discovery of novel diagnostics, treatments, and cures. The data is available to approved researchers worldwide, via a protected database containing only de-identified data.

Sanger Sequencing is Expected to Dominate During Forecast Period

Sanger sequencing is considered as a standard for accurate detection of single nucleotide variants and small insertions/deletions, thus it is usually preferred over other sequencing methods. With the increasing use of sanger sequencing, this segment is expected to dominate the technology category in the DNA sequencing market throughout the forecast period. Various market players are dedicated to providing better DNA sequencing services and expanding their market. In June 2023, Source Genomics, a subsidiary of Source BioScience group, announced the opening of its new laboratory in the North of England which aims to provide improved Sanger sequencing services to the northern region of England with faster turnaround time.

North America to Lead the DNA Sequencing Market

With high investment in research and development activities, technological advancements by key players, and highly advanced healthcare infrastructure in North American countries, like the United States and Canada, are expected to dominate the market with the highest value share. The supportive government initiatives for different DNA sequencing techniques are embracing the growth of market in the region. In May 2023, The National Institutes of Health (NIH) launched a new program, the Common Fund's Somatic Mosaicism Across Human Tissues (SMaHT) Network worth USD 140 million to explore knowledge about genetic variation in normal human cells and tissues.

Impact of COVID-19

The COVID-19 pandemic had a significant impact on DNA Sequencing market. The prioritization of COVID-19-related care led to an increase in the use of DNA sequencing methods for addressing the virus but simultaneously reduced other applications. Next-generation sequencing methods gained huge interest in the diagnosis of COVID-19. Rising COVID-19 cases in the year 2021 significantly boosted the demand for diagnostic products involving DNA sequencing, propelling the market growth. Furthermore, the pandemic negatively influenced the supply chain in the DNA Sequencing market, limiting the growth to some extent, but the market resumed to its usual pace soon after the pandemic restrictions were waived off and is expected to register consistent growth during the forecast period.

Key Players Landscape and Outlook

To increase their presence globally, major companies in the market are undertaking strategies such as product launches, mergers and acquisitions, and partnerships. In October 2022, PacBio announced the launch of their two new sequencing platforms, Revio and Onso. Revio is a short-read sequencing system while Onse is a long-read DNA sequencing platform for improving the sequencing outcomes of researchers. The Revio System has a U.S. list price of USD 779,000 while Onso has a U.S. list price of USD 259,000.

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on Global DNA Sequencing Market

4. Executive Summary

5. Global DNA Sequencing Market Outlook, 2017-2031F

5.1 Market Size & Forecast
- 5.1.1. By Value
- 5.1.2. By Volume
5.2. By Product Type
- 5.2.1. Consumables
- 5.2.2. Instruments
- 5.2.3. Services
5.3. By Technology
- 5.3.1. Sanger Sequencing
- 5.3.2. Next-Generation Sequencing
- 5.3.3. Other Sequencing Technologies
5.4. By Application
- 5.4.1. Diagnostic Applications
- 5.4.2. Personalized Medicine
- 5.4.3. Research Applications
  - 5.4.3.1. Forensics
  - 5.4.3.2. Agriculture
  - 5.4.3.3. Drug Development
  - 5.4.3.4. Others
5.5. By End-users
- 5.5.1 Hospitals and Healthcare Organizations
- 5.5.2 Academics and Research Institutions
- 5.5.3 Pharmaceutical and Biotechnology Companies
- 5.5.4 Others
5.6 By Region
- 5.6.1 North America
- 5.6.2 Europe
- 5.6.3 Asia Pacific
- 5.6.4 South America
- 5.6.5 Middle East & Africa
5.7 By Company Market Share (%), 2023

6. Global DNA Sequencing Market Outlook, By Region, 2017-2031F

6.1. North America
- 6.1.1. Market Size & Forecast
  - 6.1.1.1. By Value
  - 6.1.1.2. By Volume
- 6.1.2. By Product Type
  - 6.1.2.1. Consumables
  - 6.1.2.2. Instruments
  - 6.1.2.3. Services
- 6.1.3. By Technology
  - 6.1.3.1. Sanger Sequencing
  - 6.1.3.2. Next-Generation Sequencing
  - 6.1.3.3. Other Sequencing Technologies
- 6.1.4. By Application
  - 6.1.4.1. Diagnostic Applications
  - 6.1.4.2. Personalized Medicine
  - 6.1.4.3. Research Applications
  - 6.1.4.3.1. Forensics
  - 6.1.4.3.2. Agriculture
  - 6.1.4.3.3. Drug Development
  - 6.1.4.3.4. Others
- 6.1.5. By End-users
  - 6.1.5.1. Hospitals and Healthcare Organizations
  - 6.1.5.2. Academics and Research Institutions
  - 6.1.5.3. Pharmaceutical and Biotechnology Companies
  - 6.1.5.4. Others
- 6.1.6. United States*
  - 6.1.6.1. Market Size & Forecast
  - 6.1.6.1.1. By Value
  - 6.1.6.1.2. By Volume
  - 6.1.6.2. By Product Type
  - 6.1.6.2.1. Consumables
  - 6.1.6.2.2. Instruments
  - 6.1.6.2.3. Services
  - 6.1.6.3. By Technology
  - 6.1.6.3.1. Sanger Sequencing
  - 6.1.6.3.2. Next-Generation Sequencing
  - 6.1.6.3.3. Other Sequencing Technologies
  - 6.1.6.4. By Application
  - 6.1.6.4.1. Diagnostic Applications
  - 6.1.6.4.2. Personalized Medicine
  - 6.1.6.4.3. Research Applications
  - 6.1.6.4.3.1. Forensics
  - 6.1.6.4.3.2. Agriculture
  - 6.1.6.4.3.3. Drug Development
  - 6.1.6.4.3.4. Others
  - 6.1.6.5. By End-users
  - 6.1.6.5.1. Hospitals and Healthcare Organizations
  - 6.1.6.5.2. Academics and Research Institutions
  - 6.1.6.5.3. Pharmaceutical and Biotechnology Companies
  - 6.1.6.5.4. Others
- 6.1.7. Canada
- 6.1.8. Mexico

All segments will be provided for all regions and countries covered:

6.2. Europe
- 6.2.1. Germany
- 6.2.2. France
- 6.2.3. Italy
- 6.2.4. United Kingdom
- 6.2.5. Russia
- 6.2.6. Netherlands
- 6.2.7. Spain
- 6.2.8. Turkey
- 6.2.9. Poland
6.3. South America
- 6.3.1. Brazil
- 6.3.2. Argentina
6.4. Asia-Pacific
- 6.4.1. India
- 6.4.2. China
- 6.4.3. Japan
- 6.4.4. Australia
- 6.4.5. Vietnam
- 6.4.6. South Korea
- 6.4.7. Indonesia
- 6.4.8. Philippines
6.5. Middle East & Africa
- 6.5.1. Saudi Arabia
- 6.5.2. UAE
- 6.5.3. South Africa

7. Market Mapping, 2023

7.1. By Type
7.2. By Technology
7.3. By Application
7.4. By End-users
7.5. By Region

8. Macro Environment and Industry Structure

8.1. Supply Demand Analysis
8.2. Import Export Analysis - Volume and Value
8.3. Supply/Value Chain Analysis
8.4. PESTEL Analysis
- 8.4.1. Political Factors
- 8.4.2. Economic System
- 8.4.3. Social Implications
- 8.4.4. Technological Advancements
- 8.4.5. Environmental Impacts
- 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
8.5. Porter's Five Forces Analysis
- 8.5.1. Supplier Power
- 8.5.2. Buyer Power
- 8.5.3. Substitution Threat
- 8.5.4. Threat from New Entrant
- 8.5.5. Competitive Rivalry

9. Market Dynamics

9.1. Growth Drivers
9.2. Growth Inhibitors (Challenges, Restraints)

10. Regulatory Framework and Innovation

10.1. Clinical Trials
10.2. Patent Landscape
10.3. Regulatory Approvals
10.4. Innovations/Emerging Technologies

11. Key Players Landscape

11.1. Competition Matrix of Top Five Market Leaders
11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
11.4. SWOT Analysis (For Five Market Players)
11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

14.1. Illumina, Inc.,
- 14.1.1. Company Details
- 14.1.2. Key Management Personnel
- 14.1.3. Products & Services
- 14.1.4. Financials (As reported)
- 14.1.5. Key Market Focus & Geographical Presence
- 14.1.6. Recent Developments
14.2. Thermo-Fischer scientific
14.3. BGI genomics
14.4. Agilent Technologies Inc.
14.5. 10X Genomics
14.6. QIAGEN
14.7. F. Hoffmann-La Roche Ltd
14.8. Merck KGaA
14.9. PerkinElmer Inc.
14.10. Myriad Genetics Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

DNAシーケンシングの世界市場の評価、製品タイプ別、技術別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Global DNA Sequencing Market Assessment, By Product Type, By Technology, By Application, By End-users, By Region, Opportunities and Forecast, 2017-2031F

慢性疾患と遺伝性疾患の有病率の増加

成長する研究開発

北米がDNAシーケンシング市場をリード

COVID-19の影響

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 世界のDNAシーケンシング市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 世界のDNAシーケンシング市場の見通し（2017年～2031年）

第6章 世界のDNAシーケンシング市場の見通し：地域別（2017年～2031年）

第7章 市場マッピング（2023年）

第8章 マクロ環境と産業構造

第9章 市場力学

第10章 規制枠組みとイノベーション

第11章 主要企業情勢

第12章 価格分析

第13章 ケーススタディ

第14章 主要企業の見通し

第15章 戦略的推奨事項

第16章 当社について、免責事項